{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:13:10Z","timestamp":1775477590199,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T00:00:00Z","timestamp":1710633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T00:00:00Z","timestamp":1710633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-024-07445-x","type":"journal-article","created":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T20:01:42Z","timestamp":1710705702000},"page":"2143-2152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reproductive outcomes in women opting for fertility preservation after fertility-sparing surgery for borderline ovarian tumors"],"prefix":"10.1007","volume":"309","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0492-0221","authenticated-orcid":false,"given":"S.","family":"Cosyns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Van Moer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"De Quick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Tournaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,17]]},"reference":[{"issue":"Suppl 2","key":"7445_CR1","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/S0893-3952(22)04457-X","volume":"18","author":"WR Hart","year":"2005","unstructured":"Hart WR (2005) Borderline epithelial tumors of the ovary. Mod Pathol 18(Suppl 2):S33-50","journal-title":"Mod Pathol"},{"issue":"8","key":"7445_CR2","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.humpath.2004.03.003","volume":"35","author":"SG Silverberg","year":"2004","unstructured":"Silverberg SG, Bell DA, Kurman RJ, Seidman JD, Prat J, Ronnett BM et al (2004) Borderline ovarian tumors: key points and workshop summary. Hum Pathol 35(8):910\u2013917","journal-title":"Hum Pathol"},{"issue":"3","key":"7445_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bpobgyn.2011.12.006","volume":"26","author":"CG Trope","year":"2012","unstructured":"Trope CG, Kaern J, Davidson B (2012) Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol 26(3):325\u2013336","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"8","key":"7445_CR4","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1002\/ijc.23724","volume":"123","author":"I Skirnisdottir","year":"2008","unstructured":"Skirnisdottir I, Garmo H, Wilander E, Holmberg L (2008) Borderline ovarian tumors in Sweden 1960\u20132005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer 123(8):1897\u20131901","journal-title":"Int J Cancer"},{"issue":"3","key":"7445_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.tjog.2016.04.005","volume":"55","author":"Y Huang","year":"2016","unstructured":"Huang Y, Zhang W, Wang Y (2016) The feasibility of fertility-sparing surgery in treating advanced-stage borderline ovarian tumors: a meta-analysis. Taiwan J Obstet Gynecol 55(3):319\u2013325","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"3","key":"7445_CR6","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1016\/S1470-2045(11)70288-1","volume":"13","author":"P Morice","year":"2012","unstructured":"Morice P, Uzan C, Fauvet R, Gouy S, Duvillard P, Darai E (2012) Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol 13(3):e103\u2013e115","journal-title":"Lancet Oncol"},{"issue":"1","key":"7445_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ygyno.2009.03.001","volume":"114","author":"DM Gershenson","year":"2009","unstructured":"Gershenson DM, Sun CC, Bodurka D, Coleman RL, Lu KH, Sood AK et al (2009) Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant. Gynecol Oncol 114(1):48\u201352","journal-title":"Gynecol Oncol"},{"issue":"6","key":"7445_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/01.pas.0000164030.82810.db","volume":"29","author":"TA Longacre","year":"2005","unstructured":"Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR (2005) Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up. Am J Surg Pathol 29(6):707\u2013723","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"7445_CR9","first-page":"471","volume":"30","author":"C Trope","year":"2009","unstructured":"Trope C, Davidson B, Paulsen T, Abeler VM, Kaern J (2009) Diagnosis and treatment of borderline ovarian neoplasms \u201cthe state of the art.\u201d Eur J Gynaecol Oncol 30(5):471\u2013482","journal-title":"Eur J Gynaecol Oncol"},{"issue":"3","key":"7445_CR10","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1245\/s10434-011-2039-y","volume":"19","author":"R Fauvet","year":"2012","unstructured":"Fauvet R, Demblocque E, Morice P, Querleu D, Darai E (2012) Behavior of serous borderline ovarian tumors with and without micropapillary patterns: results of a French multicenter study. Ann Surg Oncol 19(3):941\u2013947","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"7445_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/humupd\/dms047","volume":"19","author":"E Darai","year":"2013","unstructured":"Darai E, Fauvet R, Uzan C, Gouy S, Duvillard P, Morice P (2013) Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update 19(2):151\u2013166","journal-title":"Hum Reprod Update"},{"issue":"Suppl 1","key":"7445_CR12","doi-asserted-by":"publisher","first-page":"i20","DOI":"10.1093\/annonc\/mdw090","volume":"27","author":"A du Bois","year":"2016","unstructured":"du Bois A, Trillsch F, Mahner S, Heitz F, Harter P (2016) Management of borderline ovarian tumors. Ann Oncol 27(Suppl 1):i20\u2013i22","journal-title":"Ann Oncol"},{"issue":"4","key":"7445_CR13","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1471-0528.2002.01359.x","volume":"109","author":"S Camatte","year":"2002","unstructured":"Camatte S, Morice P, Pautier P, Atallah D, Duvillard P, Castaigne D (2002) Fertility results after conservative treatment of advanced stage serous borderline tumour of the ovary. BJOG 109(4):376\u2013380","journal-title":"BJOG"},{"issue":"1","key":"7445_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<141::AID-CNCR17>3.0.CO;2-2","volume":"82","author":"WH Gotlieb","year":"1998","unstructured":"Gotlieb WH, Flikker S, Davidson B, Korach Y, Kopolovic J, Ben-Baruch G (1998) Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome. Cancer 82(1):141\u2013146","journal-title":"Cancer"},{"issue":"7","key":"7445_CR15","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1245\/s10434-020-09250-7","volume":"28","author":"S Gouy","year":"2021","unstructured":"Gouy S, Maria S, Faron M, Maulard A, Pautier P, Leary A et al (2021) Results after conservative surgery of stage ii\/iii serous borderline ovarian tumors. Ann Surg Oncol 28(7):3597\u20133604","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"7445_CR16","first-page":"541","volume":"95","author":"RT Morris","year":"2000","unstructured":"Morris RT, Gershenson DM, Silva EG, Follen M, Morris M, Wharton JT (2000) Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol 95(4):541\u2013547","journal-title":"Obstet Gynecol"},{"issue":"2","key":"7445_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.fertnstert.2004.10.009","volume":"83","author":"R Fauvet","year":"2005","unstructured":"Fauvet R, Poncelet C, Boccara J, Descamps P, Fondrinier E, Darai E (2005) Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study. Fertil Steril 83(2):284\u2013290","journal-title":"Fertil Steril"},{"issue":"6","key":"7445_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/molehr\/gav013","volume":"21","author":"N De Munck","year":"2015","unstructured":"De Munck N, Petrussa L, Verheyen G, Staessen C, Vandeskelde Y, Sterckx J et al (2015) Chromosomal meiotic segregation, embryonic developmental kinetics and DNA (hydroxy)methylation analysis consolidate the safety of human oocyte vitrification. Mol Hum Reprod 21(6):535\u2013544","journal-title":"Mol Hum Reprod"},{"issue":"11","key":"7445_CR19","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1093\/humrep\/dew208","volume":"31","author":"M De Vos","year":"2016","unstructured":"De Vos M, Smitz J, Thompson JG, Gilchrist RB (2016) The definition of IVM is clear-variations need defining. Hum Reprod 31(11):2411\u20132415","journal-title":"Hum Reprod"},{"key":"7445_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejca.2019.01.021","volume":"111","author":"M Delle Marchette","year":"2019","unstructured":"Delle Marchette M, Ceppi L, Andreano A, Bonazzi CM, Buda A, Grassi T et al (2019) Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery. Eur J Cancer 111:61\u201368","journal-title":"Eur J Cancer"},{"issue":"2","key":"7445_CR21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ygyno.2020.02.007","volume":"157","author":"H Plett","year":"2020","unstructured":"Plett H, Harter P, Ataseven B, Heitz F, Prader S, Schneider S et al (2020) Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors. Gynecol Oncol 157(2):411\u2013417","journal-title":"Gynecol Oncol"},{"issue":"2","key":"7445_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1515\/hmbci-2019-0072","volume":"43","author":"M Poulain","year":"2020","unstructured":"Poulain M, Vandame J, Tran C, Koutchinsky S, Pirtea P, Ayoubi JM (2020) Fertility preservation in borderline ovarian tumor patients and survivors. Horm Mol Biol Clin Investig 43(2):179\u2013186","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"Suppl 6","key":"7445_CR23","doi-asserted-by":"publisher","first-page":"vi160","DOI":"10.1093\/annonc\/mdt199","volume":"24","author":"FA Peccatori","year":"2013","unstructured":"Peccatori FA, Azim HA Jr, Orecchia R, Hoekstra HJ, Pavlidis N, Kesic V et al (2013) Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):vi160\u2013vi170","journal-title":"Ann Oncol"},{"issue":"1","key":"7445_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.fertnstert.2012.09.028","volume":"99","author":"Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology","year":"2013","unstructured":"Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology (2013) Mature oocyte cryopreservation: a guideline. Fertil Steril 99(1):37\u201343","journal-title":"Fertil Steril"},{"issue":"2","key":"7445_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1472-6483(10)60204-0","volume":"17","author":"E Porcu","year":"2008","unstructured":"Porcu E, Venturoli S, Damiano G, Ciotti PM, Notarangelo L, Paradisi R et al (2008) Healthy twins delivered after oocyte cryopreservation and bilateral ovariectomy for ovarian cancer. Reprod Biomed Online 17(2):265\u2013267","journal-title":"Reprod Biomed Online"},{"key":"7445_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejogrb.2020.07.053","volume":"253","author":"S Khiat","year":"2020","unstructured":"Khiat S, Provansal M, Bottin P, Saias-Magnan J, Metzler-Guillemain C, Courbiere B (2020) Fertility preservation after fertility-sparing surgery in women with borderline ovarian tumours. Eur J Obstet Gynecol Reprod Biol 253:65\u201370","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"7445_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/humrep\/det420","volume":"29","author":"EB Prasath","year":"2014","unstructured":"Prasath EB, Chan ML, Wong WH, Lim CJ, Tharmalingam MD, Hendricks M et al (2014) First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Hum Reprod 29(2):276\u2013278","journal-title":"Hum Reprod"},{"issue":"8","key":"7445_CR28","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s10815-015-0528-9","volume":"32","author":"I Segers","year":"2015","unstructured":"Segers I, Mateizel I, Van Moer E, Smitz J, Tournaye H, Verheyen G et al (2015) In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising \u201cex vivo\u201d method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe. J Assist Reprod Genet 32(8):1221\u20131231","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"7445_CR29","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s10815-020-01733-6","volume":"37","author":"F Filippi","year":"2020","unstructured":"Filippi F, Martinelli F, Somigliana E, Franchi D, Raspagliesi F, Chiappa V (2020) Oocyte cryopreservation in two women with borderline ovarian tumor recurrence. J Assist Reprod Genet 37(5):1213\u20131216","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"7445_CR30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ygyno.2007.01.036","volume":"105","author":"JY Huang","year":"2007","unstructured":"Huang JY, Buckett WM, Gilbert L, Tan SL, Chian RC (2007) Retrieval of immature oocytes followed by in vitro maturation and vitrification: a case report on a new strategy of fertility preservation in women with borderline ovarian malignancy. Gynecol Oncol 105(2):542\u2013544","journal-title":"Gynecol Oncol"},{"issue":"9","key":"7445_CR31","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1093\/humrep\/deaa175","volume":"35","author":"I Segers","year":"2020","unstructured":"Segers I, Bardhi E, Mateizel I, Van Moer E, Schots R, Verheyen G et al (2020) Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes. Hum Reprod 35(9):2026\u20132036","journal-title":"Hum Reprod"},{"issue":"2","key":"7445_CR32","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S1470-2045(20)30594-5","volume":"22","author":"RL Mulder","year":"2021","unstructured":"Mulder RL, Font-Gonzalez A, Hudson MM, van Santen HM, Loeffen EAH, Burns KC et al (2021) Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol 22(2):e45\u2013e56","journal-title":"Lancet Oncol"},{"key":"7445_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ctrv.2016.06.010","volume":"49","author":"G Mangili","year":"2016","unstructured":"Mangili G, Somigliana E, Giorgione V, Martinelli F, Filippi F, Petrella MC et al (2016) Fertility preservation in women with borderline ovarian tumours. Cancer Treat Rev 49:13\u201324","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"7445_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/humrep\/dex352","volume":"33","author":"R Masciangelo","year":"2018","unstructured":"Masciangelo R, Bosisio C, Donnez J, Amorim CA, Dolmans MM (2018) Safety of ovarian tissue transplantation in patients with borderline ovarian tumors. Hum Reprod 33(2):212\u2013219","journal-title":"Hum Reprod"},{"issue":"22","key":"7445_CR35","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1182\/blood-2012-07-439539","volume":"120","author":"MM Dolmans","year":"2012","unstructured":"Dolmans MM (2012) Safety of ovarian autotransplantation. Blood 120(22):4275\u20134276","journal-title":"Blood"},{"issue":"3","key":"7445_CR36","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ygyno.2021.03.023","volume":"161","author":"F Falcone","year":"2021","unstructured":"Falcone F, Breda E, Ferrandina G, Malzoni M, Perrone AM, Cormio G et al (2021) Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. An analysis from the MITO14 study database. Gynecol Oncol 161(3):825\u2013831","journal-title":"Gynecol Oncol"},{"issue":"2","key":"7445_CR37","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/humrep\/dez307","volume":"35","author":"SZ Jia","year":"2020","unstructured":"Jia SZ, Xiang Y, Yang JJ, Shi JH, Jia CW, Leng JH (2020) Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study. Hum Reprod 35(2):328\u2013339","journal-title":"Hum Reprod"},{"issue":"11","key":"7445_CR38","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/aogs.13203","volume":"96","author":"L Helpman","year":"2017","unstructured":"Helpman L, Yaniv A, Beiner ME, Aviel-Ronen S, Perri T, Ben-Baruch G et al (2017) Fertility preservation in women with borderline ovarian tumors - how does it impact disease outcome? A cohort study. Acta Obstet Gynecol Scand 96(11):1300\u20131306","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07445-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-024-07445-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07445-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T05:08:58Z","timestamp":1713157738000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-024-07445-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,17]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["7445"],"URL":"https:\/\/doi.org\/10.1007\/s00404-024-07445-x","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,17]]},"assertion":[{"value":"4 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm not to have any potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and was approved by the Ethical Committee of the Universitair Ziekenhuis Brussel (B.U.N. 1432021000518). The study was performed in accordance with the endorsed guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human or animals rights"}},{"value":"Informed consent was obtained from all individual participants included in the study. At the moment of cryopreservation, the possibility of data-analysis for research was discussed and approved.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}